Month: March 2022

Publicis Groupe Named Ad Age’s First-Ever Holding Company of the Year

Written by Customer Service on March 14, 2022. Posted in Public Companies.

Publicis Groupe Named Ad Age’s First-Ever Holding Company of the Year Publicis Groupe Earns Inaugural Holding Company Designation within A-List & Creativity Awards Additionally Awarded Across Agency & Leadership Categories March 14, 2022 – Publicis Groupe [Euronext Paris: FR0000130577, CAC 40] has been honored as Ad Age’s Holding Company of the Year in the publication’s annual A-List and Creativity Awards. 2022 marks the first year that Ad Age has included a Holding Company category in its awards program. The Ad Age A-List & Creativity Awards recognizes “forward-thinking leaders, top agencies and creative innovators” who pursue “game-changing creativity, bold leadership and have helped point the industry in new directions.” This honor complements additional recognition for several Publicis Groupe agencies across...

Solid Biosciences Reports Fourth Quarter and Full-Year 2021 Financial Results and 2-Year Efficacy and Safety Data from the Ongoing Phase I/II IGNITE DMD Clinical Trial of SGT-001

Written by Customer Service on March 14, 2022. Posted in Earnings Releases And Operating Results.

– 2-year data from first three patients in the high dose (2E14 vg/kg) cohort suggest sustained or improved motor function, pulmonary function and clinically validated patient-reported outcomes compared with expected declines reported by natural history data – – 90-day biopsy data from most recently dosed patients show microdystrophin expression that is consistent with earlier high dose (2E14vg/kg) cohort patients – – Company to present updated IGNITE DMD data at the 2022 Muscular Dystrophy Association Clinical & Scientific Conference – – Company advances SGT-001 clinical and regulatory strategies toward End of Phase II FDA discussions; Pipeline expansion activities continue for next generation Duchenne program, SGT-003; Company ends 2021 with $207.8 million in cash and investments – CAMBRIDGE,...

Yoshitsu Co., Ltd to Report First Six Months of Fiscal Year 2022 Financial Results on Tuesday, March 29, 2022

Written by Customer Service on March 14, 2022. Posted in Public Companies.

Earnings Call Scheduled for 8:00 am U.S. Eastern Time on March 29, 2022 Tokyo, Japan, March 14, 2022 (GLOBE NEWSWIRE) — Yoshitsu Co., Ltd (“Yoshitsu” or the “Company”) (Nasdaq: TKLF), a retailer and wholesaler of Japanese beauty and health products, as well as other products in Japan, today announced that it will release its unaudited financial results for the first six months of fiscal year 2022 before the U.S. market opens on Tuesday, March 29, 2022. The Company will host an earnings conference call to discuss its financial results at 8:00 am U.S. Eastern Time (9:00 pm Japan Standard Time) on March 29, 2022. To attend this earnings conference call, please use the information below for dial-in access.Dial-in details for the conference call are as follows:Date: March 29, 2022Time: 8:00 am U.S. Eastern TimeInternational: 1-412-902-4272United...

The Metals Company Announces Fourth Quarter 2021 Corporate Update Conference Call for Thursday, March 24, 2022 and Upcoming Conference Schedule

Written by Customer Service on March 14, 2022. Posted in Public Companies.

NEW YORK, March 14, 2022 (GLOBE NEWSWIRE) — The Metals Company (Nasdaq: TMC) (“TMC” or “the Company”), a explorer of lower-impact battery metals from seafloor polymetallic nodules, today announced that it will host a conference call on Thursday, March 24, 2022, to provide an update on fourth quarter financial results. Fourth Quarter 2021 Conference Call DetailsDate: Thursday, March 24, 2022Time: 04:30 p.m. Eastern Daylight Time Virtual webcast Register Here Toll-free dial-in number: (844) 200-6205International dial-in number: (929) 526-1599Conference ID: 060819Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Gateway Investor Relations...

REMINDER – Conference Call Notice: Intertape Polymer Group Inc. Fourth Quarter 2021 and Annual Results

Written by Customer Service on March 14, 2022. Posted in Public Companies.

MONTREAL and SARASOTA, Fla., March 14, 2022 (GLOBE NEWSWIRE) —DATE: Tuesday, March 15 2022 TIME: 10:00 A.M. (Eastern Time) DIAL-IN #: 877-291-4570 (USA & Canada) DIAL-IN# 647-788-4919 (International)AN ACCOMPANYING PRESENTATION WILL ALSO BE AVAILABLE. DETAILS FOR ACCESS WILL BE INCLUDED IN THE FOURTH QUARTER PRESS RELEASE. CONFERENCE CALL WILL BE AVAILABLE BY WEBCAST Click on following link to pre-register https://onlinexperiences.com/Launch/QReg/ShowUUID=41FABFC7-E33A-4869-A1A6-7C514464F669 DIGITIZED REPLAY DIAL-IN #: 800-585-8367 (USA & Canada) DIAL-IN #: 416-621-4642 (International) ACCESS CODE: 1166606 SCHEDULE: March 15 @ 1h00 p.m. ending April 15 @ 11:59 p.m. E.T.FOURTH QUARTER RESULTS WILL BE PUBLISHED BEFORE MARKET OPENS, MARCH 15 THROUGH...

Alkame Holdings Begins Production of Maury Island Farm Jams and Quinn’s Pepper Jellies

Written by Customer Service on March 14, 2022. Posted in Public Companies.

LAS VEGAS, March 14, 2022 (GLOBE NEWSWIRE) — Alkame Holdings, Inc. (OTC PINK: ALKM) is pleased to announce that its wholly owned subsidiary, West Coast Copacker is beginning production of Maury Island Farms Jams and Quinn’s Pepper Jellies. These 2 long standing Pacific Northwest brands were acquired by ALKM earlier this year and the company has already made huge strides in transitioning the ownership and integration of both new and existing sales and distribution partnerships and platforms as well as beginning its entry into the direct-to-consumer sector. “We are very excited to finally begin the physical production of Quinn’s and Maury Island,” stated Alkame CEO Robert Eakle. “Our entry into these stable business sectors with two long established clean label premium local brands will provide steady growth for years to come.” About...

DATA443 DEPLOYS MARKET LEADING DATA PRODUCT FOR FLAGSHIP GLOBAL BANK IN UAE – EMIRATES NBD

Written by Customer Service on March 14, 2022. Posted in Public Companies.

Data Product Selected and Deployed After Rigorous Product Selection as Company Pursues Market Uplist RESEARCH TRIANGLE PARK, NC, March 14, 2022 (GLOBE NEWSWIRE) — Data443 Risk Mitigation, Inc. (“Data443” or the “Company”) (OTCPK: ATDSD, OTCPK: ATDS), the leading data security and privacy software company for ALL THINGS DATA SECURITY™, is pleased to announce its partnership with Emirates NBD Group, a leading banking group in the MENAT (Middle East, North Africa and Turkey) region for the deployment of its market-leading data product. The multi-year subscription-based agreement spans the technology landscape of the bank and is part of the banks’ strategic plan to support its ‘cloud first’ approach to rapidly migrate its data and user base to the cloud. Miguel Rio-Tinto, Group Chief Information Officer, Emirates NBD, commented, “As...

Form 8.3 – Pearson plc

Written by Customer Service on March 14, 2022. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: Jupiter Fund Management Plc(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Pearson plc(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e) Date dealing undertaken: For an opening position disclosure,...

Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights

Written by Customer Service on March 14, 2022. Posted in Earnings Releases And Operating Results.

Immunology and CNS Programs Entering the Clinic in 2022 for Organ Transplantation, Cocaine Intoxication, Fibromyalgia, PTSD, Migraine Headache and Binge Eating Disorder Covid-19 Programs Include Upcoming Phase 2 Trial in Long Covid, Results of First-in-Human T Cell Immunity Skin Test and New Versions of Our Live Virus Covid-19 Vaccine That Express Spike Proteins From the Omicron and BA.2 Variants Expansion of Internal Research and Development Capabilities Underway to Accelerate Infectious Disease Programs and Prepare for Future Pandemic Responses Orphan-Drug Designation Granted for TNX-2900 (Intranasal Potentiated Oxytocin) for Prader-Willi Syndrome Cash and Cash Equivalents Totaled Approximately $179 Million at December 31, 2021 CHATHAM, N.J., March 14, 2022 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP)...

AVEO Oncology Reports Full Year and Fourth Quarter 2021 Financial Results

Written by Customer Service on March 14, 2022. Posted in Earnings Releases And Operating Results.

– Total 2021 Net Revenue of $42.3 Million – – FOTIVDA® (tivozanib) U.S. Net Product Revenue of $38.9 Million since March 22, 2021 – – FOTIVDA U.S. Net Product Revenue of $16.8 Million for 4Q 2021, Driven by a 26% Increase in Prescriptions Filled Compared to 3Q 2021 – – Full Year 2022 FOTIVDA U.S. Net Product Revenue Guidance of $100 to $110 Million – – Long-term data from pivotal TIVO-3 study presented at ASCO GU 2022 continue to demonstrate durable disease control and positive trend for overall survival for FOTIVDA – – Company to Host Conference Call Today at 8:30 a.m. ET – BOSTON, March 14, 2022 (GLOBE NEWSWIRE) — AVEO Oncology (Nasdaq: AVEO), a commercial stage, oncology-focused biopharmaceutical company, today reported financial results for the fourth quarter and full year ended December 31, 2021, and provided financial guidance...

Month: March 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals